Bulevirtide 2mg-based real-life treatment of hepatitis Delta with genotypes 1 and 5 viruses at more than 20 months of follow-up: Bulevirtide real-life treatment of hepatitis Delta von Dassetto, Clara, Borentain, Patrick, Gérolami, René, Colson, Philippe

Volltext

SAT-048 Long-term mortality and risk factors associated with mortality after liver transplantation in the modern era von Meszaros, Magdalena, Coilly, Audrey, Francoz, Claire, Conti, Filomena, Duvoux, Christophe, Dumortier, Jérôme, Antonini, Teresa, Dharancy, Sébastien, Hilleret, Marie-Noëlle, Del Bello, Arnaud, Anty, Rodolphe, Weil-Verhoeven, Delphine, Latournerie, Marianne, Houssel-Debry, Pauline, Dassetto, Clara, Chermak, Faiza, Faitot, François, Elkrief, Laure, Perignon, Claire, Abergel, Armand, Charpy, Flora, Molinari, Nicolas, Pageaux, Georges-Philippe

Volltext

Bulevirtide 2mg-based real-life treatment of hepatitis Delta with genotypes 1 and 5 viruses at more than 20 months of follow-up von Dassetto, Clara, Borentain, Patrick, Gérolami, René, Colson, Philippe

Volltext